Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Willeke van Roon-Mom

Assistant Professor

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

About

Willeke van Roon-Mom is an Assistant Professor at Leiden University Medical Center in the Netherlands. Her research focuses on neurodevelopmental disorders, particularly the use of antisense oligonucleotide treatments, machine learning applications in Huntington's disease, and therapeutic strategies for spinocerebellar ataxia. She has contributed to various publications discussing patient selection for individualized treatments and the safety assessments of antisense oligonucleotides.

Articles (14)

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Eleni Mina

Senior researcher

Leiden University Medical Center

NETHERLANDS

View details

Annemieke Aartsma-Rus

Professor of Translational Genetics

Leiden University Medical Center

NETHERLANDS

View details

Ronald A.M. Buijsen

Leiden University Medical Center

NETHERLANDS

View details

Aurélie Goyenvalle

Université Paris-Saclay

FRANCE

View details

Alex Garanto

Assistant Professor & Junior Principal Investigator

Radboudumc

NETHERLANDS

View details

Matthis Synofzik

Professor

Hertie Institute for clinical brain research

GERMANY

View details

Virginia Arechavala-Gomeza

Ikerbasque Professor

Ikerbasque, Basque Foundation for Science

SPAIN

View details

Katy Wolstencroft

Associate Professor

Amsterdam University Medical Centers

NETHERLANDS

View details

David Parfitt

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Willeke van Roon-Mom

Research Interests

Explore related searches

About

Articles (14)

Generation of 4 human induced pluripotent stem cell lines (LUMCi070-A, −B, −C, and −D) from a patient with ischemic cerebral small vessel disease

Impedance-based phenotypic profiling of metabotropic glutamate receptor ligand responses in SCA1 human iPSC-derived neuronal cultures

Treatability of the KMT2-Associated Neurodevelopmental Disorders Using Antisense Oligonucleotide-Based Treatments

Practical Recommendations for the Selection of Patients for Individualized Splice-Switching ASO-Based Treatments

Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction

Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations

From Failure to Meet the Clinical Endpoint to U.S. Food and Drug Administration Approval: 15th Antisense Oligonucleotide Therapy Approved Qalsody (Tofersen) for Treatment of SOD1 Mutated Amyotrophic Lateral Sclerosis

Therapeutic Strategies for Spinocerebellar Ataxia Type 1

Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.

Consensus Guidelines for the Design and <i>In Vitro</i> Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides.

Post-mortem 7T MR imaging and neuropathology in middle stage juvenile-onset Huntington disease: A case report.

Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities.

Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia.

Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease.

Collaborators (9)

Eleni Mina

Annemieke Aartsma-Rus

Ronald A.M. Buijsen

Aurélie Goyenvalle

Alex Garanto

Matthis Synofzik

Virginia Arechavala-Gomeza

Katy Wolstencroft

David Parfitt

Make your next move.